NCT06579612

Brief Summary

Pulmonary rehabilitation is an integral part of care for patients with chronic respiratory diseases. It improves patients' physical capacities, quality of life and symptoms, at least in the short term. The hypothesis that patients receiving personalized support from a professional following pulmonary rehabilitation will maintain long-term benefits. This study concerns patients with a diagnosis of one or more chronic respiratory diseases. It is a multicenter, blinded, randomized controlled superiority trial in 2 parallel arms:

  • a group comparing follow-up and personalized support after a pulmonary rehabilitation program (experimental group)
  • a control group receiving only usual care

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
352

participants targeted

Target at P75+ for not_applicable

Timeline
43mo left

Started Nov 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Nov 2024Nov 2029

First Submitted

Initial submission to the registry

August 26, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

November 7, 2024

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 7, 2029

Last Updated

August 15, 2025

Status Verified

August 1, 2025

Enrollment Period

5 years

First QC Date

August 26, 2024

Last Update Submit

August 12, 2025

Conditions

Keywords

chronic respiratory diseasepulmonary rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Difference in average number of daily steps

    The difference in average daily steps measured by accelerometry (over 7 days) at the end of the pulmonary rehabilitation course (V1) and after 24 months of personalized follow-up (V5).

    At inclusion (V1) and at 24 Months (V5)

Secondary Outcomes (13)

  • Cost-utility comparison between the two groups

    At 24 Months (V5)

  • Comparison of changes in physical activity levels between the two groups

    At 24 Months (V5)

  • Comparison of changes in physical capacities between the two groups

    A 24 Months (V5)

  • Comparison of changes in physical capacities between the two groups

    A 24 Months (V5)

  • Comparison of changes in physical capacities between the two groups

    A 24 Months (V5)

  • +8 more secondary outcomes

Study Arms (2)

Control arm

NO INTERVENTION

Patient in the control arm will beneficiate from commun practice

Experimental arm

EXPERIMENTAL

Patient in the control arm will beneficiate from a personalized follow-up and support after a pulmonary rehabilitation program

Other: Personalized follow-up and support

Interventions

After a pulmonary rehabilitation program, an interview with a professional will enable the professional to identify the barriersand enablers of physical activity engagement, and to identify (with the patient) a plan for maintaining a physical activities adapted in daily life. Adapted solutions will then be proposed.

Experimental arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of one or more chronic respiratory diseases (asthma, chronic obstructive pulmonary disease, diffuse interstitial lung disease, bronchiectasis, obstructive sleep apnea syndrome, etc.).
  • Participation in a respiratory pulmonary program
  • Have given consent
  • Patient of legal age
  • Patient affiliated to Social Security

You may not qualify if:

  • Any medical contraindication to the practice of adapted physical activity in rehabilitation
  • Patients under guardianship or curatorship
  • Patients deprived of their liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Brest

Brest, 29609, France

RECRUITING

CH des Pays de Morlaix

Morlaix, 29672, France

RECRUITING

MeSH Terms

Interventions

Palliative Care

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Marie-Agnès GIROUX-METGES, MD, PhD

    Brest Universty Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie-Agnès GIROUX-METGES, MD, PhD

CONTACT

Baptiste Chéhère, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled superiority trial in parallel arms (1:1 ratio) comparing personalized follow-up and support after a pulmonary rehabilitation program (experimental group) versus a control group receiving only usual care,
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2024

First Posted

August 30, 2024

Study Start

November 7, 2024

Primary Completion (Estimated)

November 7, 2029

Study Completion (Estimated)

November 7, 2029

Last Updated

August 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning five years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations